1. Immune thrombocytopenia among patients with cancer and its response to treatment
- Author
-
Deeb Jamil Zahran, Mahmoud H Ayesh Haj Yousef, Yousef Khader, Khaldoon Alawneh, and Najla Aldaoud
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Multivariate analysis ,business.industry ,Solid cancer ,Medical record ,Cancer ,Hematology ,General Medicine ,medicine.disease ,University hospital ,Response to treatment ,Immune thrombocytopenia ,Lymphoma ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,immune system diseases ,hemic and lymphatic diseases ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,business - Abstract
OBJECTIVES The aim of this study was to determine the rate of immune thrombocytopenia (ITP) in adult Jordanian patients diagnosed with cancer, to correlate this rate with the type of cancer and to assess the response of ITP in patients with cancer to treatment. METHODS All adult patients aged 16 years or older who had been diagnosed with cancer at King Abdullah University Hospital (KAUH) between September 2002 and October 2017 were included in this study. Their medical records were reviewed for the diagnosis of ITP. RESULTS The total number of patients diagnosed with cancer at KAUH between September 2002 and October 2017 was 8318. The majority of patients had solid cancers (87.0%), and hematological cancers constituted 13%. Fifteen (0.2%) patients with cancer had ITP. ITP was significantly more common in patients with lymphomas (1.3%) than in patients with solid cancers (0.1%) (P
- Published
- 2018
- Full Text
- View/download PDF